Nutritional product for a person having ulcerative colitis

• US 6,468,987 B1
• Filed: 09/14/1999
• Issued: 10/22/2002
• Est. Priority Date: 04/01/1994
• Status: Expired due to Term

• Current Assignee: Abbott Laboratories Incorporated
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Demichele, Stephen Joseph, Garleb, Keith Allen, Fuller, Martha Kay, McEwen, John William
• Primary Examiner(s): GEIST, GARY L
• Application Number:
  US09/395,509
• Time in Patent Office: 1,134 Days
• Field of Search: 426/567, 426/658, 514/54, 514/168, 514/188, 514/552, 514/566, 514/725, 514/810, 514/812, 514/813, 514/861
• US Class Current: 514/54
• CPC Class Codes: A23L 33/12 Fatty acids or derivatives thereof
• CPC Class Codes: A23L 33/40 Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Abstract

An enteral nutritional product for a person having ulcerative colitis contains in combination (a) an oil blend which contains eicosapentaenoic acid (20:5n3) and/or docosahexaenoic acid (22:6n3), and (b) a source of indigestible carbohydrate which is metabolized to short chain fatty acids by microorganisms present in the human colon. Preferably the nutritional product also contains one or more nutrients which act as antioxidants.

Claims

1. A nutritional product for enteral feeding comprising in combination:

(a) a source of indigestible carbohydrate which is metabolized to short chain fatty acids by microorganisms present in the human colon and which comprises at least one material selected from the group consisting of dietary fibers and indigestible oligosaccharides; and

(b) an oil blend containing certain fatty acids, expressed as percentages by weight of total fatty acids in the oil blend, as follows;

2. A nutritional product according to claim 1 comprising an oil blend containing certain fatty acids, expressed as percentages by weight of total fatty acids in the oil blend, as follows:

3. A nutritional product according to claim 1 comprising an oil blend containing certain fatty acids, expressed as percentages by weight of total fatty acids in the oil blend, as follows:

4. A nutritional product according to any of claim 1, 2 or 3 wherein, by weight, the ratio of the sum of all of the n-6 fatty acids in the oil blend to the sum of all of the n-3 fatty acids in the oil blend is in the range of 0.25 to 4.0.

5. A nutritional product according to any one of claim 1, 2 or 3 wherein, by weight, the ratio of Linoleic acid (18:

2n6) in the oil blend to Alpha-Linolenic acid (18;

3n-3) in the oil blend is in the range of 3.0-10.0.

6. A nutritional product according to claim 4 wherein, by weight, the ratio of Linoleic acid (18:

2n6) in the oil blend to Alpha-Linolenic acid (18;

3n-3) in the oil blend is in the range of 3.0-10.0.

7. A nutritional product according to claim 1 wherein the source of indigestible carbohydrates comprises at least one material selected from the group consisting of gum arabic, soy polysaccharide, fructooligosaccharides, hydrolyzed inulin and xylooligosaccharides.

8. A nutritional product according to claim 1 further comprising at least one nutrient selected from the group consisting of beta-carotene, vitamin E, vitamin C, taurine and selenium.

9. A nutritional product according to claim 7 further comprising at least one nutrient selected from the group consisting of beta-carotene, vitamin E, vitamin C, taurine and selenium.

20. The nutritional product according to claim 1 further comprising a source of protein and a source of digestible carbohydrate.

21. The nutritional product according to claim 20 in which said indigestible carbohydrate is present in the quantity of about 16.9 to about 22.8 grams per liter.

22. The nutritional product according to claim 21 in which said protein provides about 18.5% to about 23.5% of total calories, said carbohydrates provide about 59% to about 63% of total calories, and said fat provides about 16 to about 18% of total calories.

23. A method for providing nutrition to a patient with ulcerative colitis comprising the administration of a nutritional product according to claim 1 to said patient.

34. The nutritional product according to claim 8 in which said beta-carotene is present in the quantity of about 2,500 to about 6,500 ug/liter.

35. The nutritional product according to claim 8 in which said vitamin E is present in the quantity of about 100 to about 450 iu/liter.

36. The nutritional product according to claim 8 in which said vitamin C is present in the quantity of about 250 to about 850 mg/liter.

37. The nutritional product according to claim 8 in which said taurine is present in the quantity of about 200 to about 350 mg/liter.

10. A nutritional product for enteral feeding comprising in combination:

(a) an oil blend which comprises, by weight, a total of at least 25% of one or more oils which contain;

Eicosapentaenoic acid (20;

5n3) and Docosahexaenoic acid (22;

6n3);

(b) a source of indigestible carbohydrate which is metabolized to short chain fatty acids by microorganisms present in the human colon and which comprises at least one material selected from the group consisting of dietary fibers and indigestible oligosaccharides; and

(c) at least on nutrient selected form the group consisting of beta-carotene, vitamin E, vitamin C, taurine and selenium.

11. A nutritional product according to claim 10 in which the oils which contain Eicosapentaenoic acid (20:

5n3) and Docosahexaenoic acid (22;

6n3) are selected from the group consisting of fish oils, marine oils, algae oils, fungal oils, and vegetable oil.

12. A nutritional product according to claim 10 wherein the source of indigestible carbohydrates is a combination of at least one dietary fiber and at least one indigestible oligosaccharide.

13. A nutritional product according to claim 10 wherein the source of indigestible carbohydrate contains at least one material selected from the group consisting of gum arabic, soy polysaccharide, fructooligosaccharides, hydrolyzed inulin and xylooligosaccharides.

24. The nutritional product according to claim 10 further comprising a source of protein and a source of digestible carbohydrate.

25. The nutritional product according to claim 24 in which said protein provides from about 18.5% to about 23.5% of total calories, said carbohydrates provide about 59% to about 63% of total calories, and said fat provides about 16 to about 18% of total calories.

26. The nutritional product according to claim 25 in which said indigestible carbohydrate is present in the quantity of about 16.9 to about 22.8 grams per liter.

27. A method for providing nutrition to a patient with ulcerative colitis comprising the administration of a nutritional product according to claim 10 to said patient.

28. A method for providing nutrition to a patient with ulcerative colitis comprising the administration of a nutritional product according to claim 26 to said patient.

14. A nutritional product for enteral feeding comprising in combination:

(a) an oil blend comprising by weight about 5-40% canola oil, about 10-50% medium chain triglycerides, about 25-80% fish oil, about 3-30% soybean oil, and about 2-6% soy lecithin;

(b) a source of indigestible carbohydrate which is metabolized to short chain fatty acids by microorganisms present in the human colon and which comprises at least one material selected from the group consisting of gum arabic, soy polysaccharide, fructooligosaccharides and xylooligosaccharides;

(c) at least one nutrient selected from the group consisting of beta-carotene, vitamin E, vitamin C, taurine and selenium; and

(d) a source of protein.

15. A nutritional product according to claim 14 wherein the oil blend further comprises at least one oil selected from the group consisting of corn oil, safflower oil, high-oleic safflower oil, high-oleic sunflower oil, olive oil, borage oil, black currant seed oil and evening primrose oil.

16. A nutritional product according to claim 14 wherein, by weight, the ratio of the sum of all of the n-6 fatty acids in the oil blend to the sum of all of the n-3 fatty acids in the oil blend is in the range of 0.25 to 4.0.

17. A nutritional product according to any one of claim 14, 15 or 16 wherein, by weight, the ratio of Linoleic acid (18:

2n6) in the oil blend to Alpha-Linolenic acid (18;

3n-3) in the oil blend is in the range of 3.0 to 10.0.

18. An enteral nutritional product according to claim 14 having about 18.5%-23.5% of total calories provided by protein, about 59.0%-63.0% of total calories provided by carbohydrate, and about 16.0%-20.0% of total calories provided by fat.

19. An enteral nutritional product according to claim 14 wherein the source of protein comprises at least one material selected from the group consisting of intact and hydrolyzed proteins of high biological value.

29. The nutritional product according to claim 14 further comprising a source of protein and a source of digestible carbohydrate.

30. The nutritional product according to claim 29 in which said indigestible carbohydrate is present in the quantity of about 16.9 to about 22.8 grams per liter.

31. The nutritional product according to claim 30 in which said protein provides from about 18.5% to about 23.5% of total calories, said carbohydrates provide from about 59% to about 63% of total calories, and said fat provides from about 16 to about 18% of total calories.

32. A method for providing nutrition to a patient with ulcerative colitis comprising the administration of a nutritional product according to claim 14 to said patient.

33. A method for providing nutrition to a patient with ulcerative colitis comprising the administration of a nutritional product according to claim 31 to said patient.

38. The nutritional product according to claim 14 in which said beta-carotene is present in the quantity of about 2,500 to about 6,500 ug/liter.

39. The nutritional product according to claim 14 in which said vitamin E is present in the quantity of about 100 to about 450 iu/liter.

40. The nutritional product according to claim 14 in which vitamin C is present in the quantity of about 250 to about 850 mg/liter.

41. The nutritional product according to claim 14 in which said taurine is present in the quantity of about 200 to about 350 mg/liter.